Logos Capital

company

About

Logos Capital is a fundamental biotechnology-focused investment fund.

  • 1 - 10

Highlights

Details

Industries
Biotechnology,Hedge Funds
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Hedge Fund,PE

Logos Capital is a fundamental biotechnology-focused fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.

Based in San Francisco, Logos combines expertise across medical, scientific, and statistical disciplines to expand the depth of diligence in identifying compelling investment ideas and uncorrelated-market returns. They combine scientific diligence with their statistical modeling of clinical trials to achieve the highest levels of conviction in each position.

Investments

Number of Investments
Number of Lead Investments
15
0
Logos Capital has made 15 investments. Their most recent investment was on Dec 6, 2022, when Entact Bio raised $81M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 6, 2022 Entact Bio
Series A $81M Biopharma
Dec 7, 2021 Freenome
Series D $300M Biotechnology
Series A $400M Biotechnology
Series Unknown $105M Biotechnology
Series C $276M Biotechnology